Table 3.
N | Hazard ratio (95% CI) | p | |
---|---|---|---|
Age, year | 1953 | 1.02 (1.003, 1.04) | 0.02 |
Male | 1953 | 1.09 (0.87, 1.38) | 0.45 |
Race | 1917 | 0.13 | |
White | Reference | ||
Black | 1.35 (1.02, 1.78) | ||
Hispanic | 0.94 (0.67, 1.31) | ||
Other | 0.93 (0.55, 1.55) | ||
Era of diagnosis | 1953 | <0.001 | |
Early cohort (1990–1999) | 1.59 (1.22, 2.09) | ||
Late cohort (2000–2010) | Reference | ||
Type | 1952 | <0.001 | |
Idiopathic | Reference | ||
Myocarditis | 0.48 (0.30, 0.76) | ||
Neuromuscular disease | 1.86 (1.36, 2.54) | ||
Familial | 0.42 (0.19, 0.94) | ||
Error of metabolism | 1.39 (0.76, 2.55) | ||
Malformation syndrome | 2.09 (0.78, 5.61) | ||
Heart failure at diagnosis | 1943 | 1.80 (1.37, 2.37) | <0.001 |
Diuretic therapy | 1890 | 1.00 (0.73, 1.38) | 0.67 |
Family history of sudden death | 1121 | 1.14 (0.71, 1.81) | 0.51 |
LVEDD‡ z-score | 1527 | 1.04 (0.99, 1.09) | 0.12 |
LVESD§ z-score | 1338 | 1.07 (1.01, 1.12) | 0.01 |
LV** fractional shortening z-score | 1580 | 0.93 (0.89, 0.96) | <0.001 |
LV posterior wall thickness z-score | 1235 | 0.94 (0.89, 1.01) | 0.08 |
Septal thickness z-score | 1127 | 0.91 (0.84, 0.99) | 0.04 |
LV mass z-score | 1217 | 1.01 (0.95, 1.06) | 0.86 |
LVEDD, left ventricular end-diastolic dimension
LVESD, left ventricular end-systolic dimension
LV, left ventricular